Symbiotec Pharmalab Limited is closed and awaiting listing, offered in a price band of ₹938 to ₹988 per share, in lots of 15 shares. Every figure below is taken from the issue's own filings and exchange disclosures.
One lot of 15 shares at the upper band price of ₹988 is ₹14,820 — the smallest retail application this issue accepts.
Lead managers: JM Financial Limited.
How many times the issue has been applied for, by investor category, as reported by the exchange at 27 Aug 2026, 07:05 pm IST.
| Category | Times subscribed |
|---|---|
| Qualified institutional buyers (QIB) | 172.03× |
| Non-institutional investors (NII / HNI) | 73.63× |
| Retail individual investors | 12.96× |
| Total | 71.26× |
How the reported premium has moved. The trend matters more than any single reading — a premium that is drifting down into the close is a different signal from one holding firm.
| Reported at | GMP |
|---|---|
| 27 Aug 2026, 07:05 pm IST | ₹275 |
| 27 Aug 2026, 04:15 pm IST | ₹275 |
| 27 Aug 2026, 03:15 pm IST | ₹285 |
| 27 Aug 2026, 02:10 pm IST | ₹285 |
| 27 Aug 2026, 01:10 pm IST | ₹285 |
| 27 Aug 2026, 12:10 pm IST | ₹285 |
| 27 Aug 2026, 11:10 am IST | ₹285 |
| 27 Aug 2026, 10:05 am IST | ₹285 |
| 27 Aug 2026, 09:00 am IST | ₹285 |
| 27 Aug 2026, 08:00 am IST | ₹285 |
| 26 Aug 2026, 09:40 pm IST | ₹333 |
| 26 Aug 2026, 07:05 pm IST | ₹333 |
Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.
As disclosed in the offer document. Figures in ₹ crore unless the filing states otherwise.
| PAT | Assets | Expense | Revenue | Period Ended |
|---|---|---|---|---|
| ₹100.06 | ₹1,294.79 | ₹590.99 | ₹723.33 | 2024 |
| ₹96.79 | ₹1,579.65 | ₹608.85 | ₹755.98 | 2025 |
| ₹109.90 | ₹1,780.79 | ₹709.90 | ₹872.26 | 2026 |
These are the company's own disclosures, not Alphave's assessment. Read the offer document →
← All current and upcoming IPOs · Open the interactive Symbiotec Pharmalab terminal →
Every Indian IPO in one place — mainboard and SME — from the day dates are announced through subscription, listing and after. Each issue carries its price band, lot size, the minimum a retail applicant needs, subscription by QIB, NII and retail category, the reported grey market premium with the time it was recorded, and the registrar and lead managers handling it.
Every tool reads the same live feed and the same filed statements, so a name you find in one opens in any of the others.
Open to everyone; the per-issue terminal needs a free account. Alphave is NISM-certified, not a SEBI-registered research analyst — nothing here is investment advice or a recommendation to buy or sell any security.